|
ABTB2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
1.721500000329E-07 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
2.921500E-02 |
| Stage1-vs-Stage3 |
5.110800E-01 |
| Stage1-vs-Stage4 |
6.472100E-02 |
| Stage2-vs-Stage3 |
7.895700E-03 |
| Stage2-vs-Stage4 |
6.615200E-04 |
| Stage3-vs-Stage4 |
3.091600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
2.4654999999929E-05 |
| Normal-vs-Asian |
8.6826101863835E-12 |
| Caucasian-vs-AfricanAmerican |
5.972200E-01 |
| Caucasian-vs-Asian |
4.887500E-02 |
| AfricanAmerican-vs-Asian |
5.710200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
2.511000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
6.859300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.824200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.963720E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.856400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.779820E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.581200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.384000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.119700E-03 |
| Classical-VS-Follicular |
1.11022302462516E-16 |
| Classical-VS-Other |
2.077600E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
<1E-12 |
| Tall-VS-Other |
6.695700E-03 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
5.935500E-02 |
| Follicular-VS-Normal |
1.98070000001493E-06 |
| Other-VS-Normal |
4.390100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
2.07467376611703E-12 |
| N0-vs-N1 |
4.223200E-03 |
|
|
